Current applications of nanoparticles in infectious diseases

H Zazo, CI Colino, JM Lanao - Journal of Controlled Release, 2016 - Elsevier
For decades infections have been treated easily with drugs. However, in the 21st century,
they may become lethal again owing to the development of antimicrobial resistance …

Nanoparticle entry into cells; the cell biology weak link

G Griffiths, J Gruenberg, M Marsh, J Wohlmann… - Advanced Drug Delivery …, 2022 - Elsevier
Nanoparticles (NP) are attractive options for the therapeutic delivery of active
pharmaceutical drugs, proteins and nucleic acids into cells, tissues and organs. Research …

Nanoantibiotics: Functions and properties at the nanoscale to combat antibiotic resistance

MM Mamun, AJ Sorinolu, M Munir… - Frontiers in …, 2021 - frontiersin.org
One primary mechanism for bacteria developing resistance is frequent exposure to
antibiotics. Nanoantibiotics (nAbts) is one of the strategies being explored to counteract the …

Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections

N Abed, P Couvreur - International journal of antimicrobial agents, 2014 - Elsevier
In the field of antibiotherapy, intracellular infections remain difficult to eradicate mainly due to
the poor intracellular penetration of most of the commonly used antibiotics. Bacteria have …

Biocompatibility of nanomaterials and their immunological properties

TR Kyriakides, A Raj, TH Tseng, H Xiao… - Biomedical …, 2021 - iopscience.iop.org
Nanomaterials (NMs) have revolutionized multiple aspects of medicine by enabling novel
sensing, diagnostic, and therapeutic approaches. Advancements in processing and …

Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections

S Subramaniam, P Joyce, N Thomas… - Advanced Drug Delivery …, 2021 - Elsevier
Bacteria have developed a wealth of strategies to avoid and resist the action of antibiotics,
one of which involves pathogens invading and forming reservoirs within host cells. Due to …

Advancements in prophylactic and therapeutic nanovaccines

P Bhardwaj, E Bhatia, S Sharma, N Ahamad… - Acta Biomaterialia, 2020 - Elsevier
Vaccines activate suitable immune responses to fight against diseases but can possess
limitations such as compromised efficacy and immunogenic responses, poor stability, and …

Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections

A Baelo, R Levato, E Julian, A Crespo, J Astola… - Journal of Controlled …, 2015 - Elsevier
Infections caused by biofilm-forming bacteria are a major threat to hospitalized patients and
the main cause of chronic obstructive pulmonary disease and cystic fibrosis. There is an …

Application of nanoparticle technologies in the combat against anti-microbial resistance

M Kumar, A Curtis, C Hoskins - Pharmaceutics, 2018 - mdpi.com
Anti-microbial resistance is a growing problem that has impacted the world and brought
about the beginning of the end for the old generation of antibiotics. Increasingly, more …

Enhanced permeability and retention-like extravasation of nanoparticles from the vasculature into tuberculosis granulomas in zebrafish and mouse models

F Fenaroli, U Repnik, Y Xu, K Johann, S Van Herck… - ACS …, 2018 - ACS Publications
The enhanced permeability and retention (EPR) effect is the only described mechanism
enabling nanoparticles (NPs) flowing in blood to reach tumors by a passive targeting …